"SV-HUC-1人輸尿管上皮永生化細(xì)胞全年復(fù)蘇|已有STR圖譜

傳代比例：1:2-1:4(首次傳代建議1:2)

生長(zhǎng)特性：貼壁生長(zhǎng)

【細(xì)胞培養(yǎng)經(jīng)驗(yàn)分享】啟蒙老師的重要性：一般進(jìn)實(shí)驗(yàn)室都有師兄師姐帶著做，他們就是你做細(xì)胞的啟蒙老師。他們的操作手法、細(xì)節(jié)、理論講解就成了你操作的準(zhǔn)則，如營(yíng)養(yǎng)液、細(xì)胞瓶的擺放位置、滅菌處理程序、開(kāi)蓋手法、細(xì)胞吹打手法等等。要學(xué)會(huì)他們的正確操作，在第一次的時(shí)候就要重視。像養(yǎng)孩子一樣養(yǎng)細(xì)胞，細(xì)胞有時(shí)真的很脆弱，最好每天都去看看它，以防止出現(xiàn)培養(yǎng)箱缺水、缺二氧化碳、停電、溫度不夠等異常現(xiàn)象，也好及時(shí)解決這些意外，避免重復(fù)實(shí)驗(yàn)帶來(lái)的更大痛苦。好細(xì)胞要及時(shí)保種：細(xì)胞要分批傳代，這樣即使有一批出了問(wèn)題，還有一批備用的。像后者一般人可能不容易做到。但這是我血的教訓(xùn)，有一次細(xì)胞污染了，全軍覆沒(méi)。當(dāng)時(shí)可后悔沒(méi)有保種。細(xì)胞跟人一樣，不同的細(xì)胞，培養(yǎng)特性是不一樣的。培養(yǎng)過(guò)程中要細(xì)細(xì)體會(huì)，不同細(xì)胞系使用不同的培養(yǎng)基和血清。

換液周期：每周2-3次

NHLF Cells;背景說(shuō)明：肺；成纖維 Cells;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：149PT細(xì)胞、A-1847細(xì)胞、Anglne細(xì)胞

HCC9204 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：BEL 7402細(xì)胞、RKO_AS45細(xì)胞、Roswell Park Memorial Institute 7666細(xì)胞

HOPC Cells;背景說(shuō)明：少突膠質(zhì)前體 Cells;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：UACC-893細(xì)胞、Normal Rat Kidney細(xì)胞、H209細(xì)胞

背景信息：是為了研究尿路上皮細(xì)胞的生長(zhǎng)、分化和功能而建立的細(xì)胞系。是正常輸尿管組織用SV40病毒轉(zhuǎn)染建株的。反復(fù)用非洲綠猴腎細(xì)胞平板測(cè)試檢測(cè)傳染性SV40的生成，結(jié)果都呈陰性；SV-HUC-1細(xì)胞在脅迫(如曝露于化學(xué)試劑)下可能激活病毒。

SV-HUC-1人輸尿管上皮永生化細(xì)胞全年復(fù)蘇|已有STR圖譜

產(chǎn)品包裝：復(fù)蘇發(fā)貨：T25培養(yǎng)瓶(一瓶)或凍存發(fā)貨：1ml凍存管(兩支)

ATCC細(xì)胞庫(kù)(American Type Culture Colection)，該中心一直致力于細(xì)胞分類、鑒定和保藏工作。ATCC是全球最大的生物資源保藏中心，ATCC通過(guò)行業(yè)標(biāo)準(zhǔn)產(chǎn)品、服務(wù)和創(chuàng)新解決方案支持全球?qū)W術(shù)、政府、生物技術(shù)、制藥、食品、農(nóng)業(yè)和工業(yè)領(lǐng)域的科學(xué)進(jìn)步。ATCC提供的服務(wù)和定制解決方案包括細(xì)胞和微生物培養(yǎng)、鑒定、生物衍生物的開(kāi)發(fā)和生產(chǎn)、性能測(cè)試和生物資源保藏服務(wù)。美國(guó)國(guó)家標(biāo)準(zhǔn)協(xié)會(huì)(ANSI)認(rèn)可了ATCC標(biāo)準(zhǔn)開(kāi)發(fā)組織，并制定了標(biāo)準(zhǔn)協(xié)議，以確保生物材料的可靠性和可重復(fù)性。ATCC的使命是為了獲取、鑒定、保存、開(kāi)發(fā)、標(biāo)準(zhǔn)化和分發(fā)生物資源和生物信息，以提高和應(yīng)用生物科學(xué)知識(shí)。

MOLP-8 Cells;背景說(shuō)明：漿細(xì)胞骨髓瘤；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Hs 742.T細(xì)胞、HSC-4細(xì)胞、SNU475細(xì)胞

Hs888T Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代；每周換液２-３次;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：成纖維細(xì)胞和上皮細(xì)胞的混合樣;相關(guān)產(chǎn)品有：C4 I細(xì)胞、LPC-H12細(xì)胞、GOS3細(xì)胞

Rat-2 Cells;背景說(shuō)明：成纖維細(xì)胞；自發(fā)永生；Fischer ３４４;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：KMS18細(xì)胞、Kit225-K6細(xì)胞、526細(xì)胞

2C12 Cells(提供STR鑒定圖譜)

來(lái)源說(shuō)明：細(xì)胞主要來(lái)源ATCC、ECACC、DSMZ、RIKEN等細(xì)胞庫(kù)

物種來(lái)源：人源、鼠源等其它物種來(lái)源

SV-HUC-1人輸尿管上皮永生化細(xì)胞全年復(fù)蘇|已有STR圖譜

形態(tài)特性：上皮細(xì)胞樣

貼壁細(xì)胞的消化方法介紹：１、胰酶。這是用得Zui多的。一般濃度在０.２５-０.５%。作用時(shí)間根據(jù)細(xì)胞種類、作用溫度等因素而變化很大，從幾分鐘到幾十分鐘不等。０.２５%的胰酶作用于單層貼壁的細(xì)胞，在３７度條件下，一般消化１-５分鐘就足夠了。終止是用血清。主要作用于細(xì)胞間。配制時(shí)不能用含、鎂的平衡，否則影響活性。保存于-２０度。２、膠原酶。這種方法比較少，一般是用原代培養(yǎng)時(shí)，從組織消化下細(xì)胞。這種方法作用溫和，對(duì)細(xì)胞損傷較小，但是，價(jià)格也較貴。中止同樣是用血清。３、EDA。用得也是非常多。一般濃度在０.０２%左右。作用于細(xì)胞與間質(zhì)，對(duì)細(xì)胞間也有一定作用。注意，它能顯著影響pH值，而且在弱堿性條件下才易溶。因此，配制時(shí)應(yīng)調(diào)節(jié)HAO堿度。它不能被終和。因此，消化下來(lái)的細(xì)胞要洗一遍。４、商品化的無(wú)酶消化。個(gè)人的使用經(jīng)常覺(jué)得對(duì)細(xì)胞的損傷比較大，但是分離成單細(xì)胞懸的能力確實(shí)比較強(qiáng)。５、物理法。直接吹打或用細(xì)胞刮子將細(xì)胞刮下來(lái)。６、冷凍法。此方法僅能用于細(xì)胞傳代時(shí)。無(wú)法使組織上的細(xì)胞脫落下來(lái)。本方法的原理，我想是因細(xì)胞冷凍后收縮，從而從培養(yǎng)瓶上脫落下來(lái)。YOU點(diǎn)是：對(duì)細(xì)胞損傷小，不需要中止或洗細(xì)胞，方便，不需要另外配制消化。別適用那些貼壁不是別緊，又別嬌氣的細(xì)胞。不足是細(xì)胞常成小片脫落。此種方法曾用于因用其它方法傳代導(dǎo)致大量細(xì)胞死亡操作的間充質(zhì)干細(xì)胞、DC細(xì)胞的培養(yǎng)，效果非常滿意。具體過(guò)程是：１、用較多的４度的PBS 洗滌一遍細(xì)胞(以６孔板為例，加１.５ml/孔)，２、再加０.５毫升４度的PBS，靜置操作臺(tái)上，很快細(xì)胞就小片脫落，３、輕輕吹打，細(xì)胞即完全脫落，４、按一定比例傳代。

Kit 225 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：NCC-IT細(xì)胞、MC3T3-L1細(xì)胞、NFHIOSE-29細(xì)胞

H-889 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：每周換液２-３次;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：上皮細(xì)胞;相關(guān)產(chǎn)品有：NCI-H1930細(xì)胞、NS-I/1細(xì)胞、SCL-1細(xì)胞

HuTu 80 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２—１：５傳代，每周換液２-３次;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮細(xì)胞樣;相關(guān)產(chǎn)品有：BT483細(xì)胞、MPC-83細(xì)胞、Nakata-1細(xì)胞

3-LL Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：CCD 966 SK細(xì)胞、SRS-82細(xì)胞、SW-954細(xì)胞

HMy2.CIR Cells;背景說(shuō)明：B細(xì)胞；EBV轉(zhuǎn)染；女性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：P3X63 Ag8.653細(xì)胞、OCI/AML3細(xì)胞、MC-38細(xì)胞

HNE1 Cells;背景說(shuō)明：鼻咽部；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：RINm5F細(xì)胞、TE-14細(xì)胞、AX-Mel細(xì)胞

NCIH1092 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：隨細(xì)胞的密度而增加;生長(zhǎng)特性：懸浮生長(zhǎng);形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：RCC-JF細(xì)胞、D283細(xì)胞、SK-OV-433細(xì)胞

Mink Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：ROS 17/28細(xì)胞、SUIT2細(xì)胞、Human Microglia Clone 3細(xì)胞

MN-60 Cells;背景說(shuō)明：B細(xì)胞白血病；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Wien133細(xì)胞、H-838細(xì)胞、HCC1599細(xì)胞

624-mel Cells;背景說(shuō)明：黑色素瘤；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HSC-5 [Human skin squamous cell carcinoma]細(xì)胞、aNK細(xì)胞、NUGC-2細(xì)胞

GM02219D Cells;背景說(shuō)明：MOLT-４與MOLT-３來(lái)源于一名１９歲的男性急性淋巴細(xì)胞性白血病的復(fù)發(fā)患者，該患者前期接受過(guò)多種藥物聯(lián)合化療。MOLT-４細(xì)胞系為T淋巴細(xì)胞起源，p５３基因的第２４８位密碼子有一個(gè)G→A突變，不表達(dá)p５３，不表達(dá)免疫球蛋白或EB病毒；可產(chǎn)生高水平的末端脫氧核糖轉(zhuǎn)移酶；表達(dá)CD１(４９%),CD２(３５%),CD３A(２６%)B(３３%)C(３４%),CD４(５５%),CD５(７２%),CD６(２２%),CD７(７７%)。;傳代方法：１：２傳代;生長(zhǎng)特性：懸浮生長(zhǎng);形態(tài)特性：淋巴母細(xì)胞樣；圓形;相關(guān)產(chǎn)品有：RMa-bm細(xì)胞、WSU-DLCL2細(xì)胞、HFT8810細(xì)胞

MES-23.5 Cells;背景說(shuō)明：多巴胺能神經(jīng)元 Cells;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：P3J.HR1K細(xì)胞、TMD-8細(xì)胞、RT4細(xì)胞

SkMel31 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：４-１：６傳代，２-３天換液１次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮細(xì)胞;相關(guān)產(chǎn)品有：CWR22R-V1細(xì)胞、LS-174細(xì)胞、32D:cl3細(xì)胞

HEL-299 Cells;背景說(shuō)明：紅白細(xì)胞白血病;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：EoL-1細(xì)胞、TE3A細(xì)胞、NCIH810細(xì)胞

GM07404 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁生長(zhǎng)　;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：639-V細(xì)胞、Pa017C細(xì)胞、OCI/AML-5細(xì)胞

PCI-04B Cells;背景說(shuō)明：喉鱗癌；淋巴結(jié)轉(zhuǎn)移；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：CAL 39細(xì)胞、SUM 190PT細(xì)胞、Stanford University-Diffuse Histiocytic Lymphoma-4細(xì)胞

KBM-7/Hap8 Cells;背景說(shuō)明：慢性髓原白血??；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HEP3B2細(xì)胞、GCT0404細(xì)胞、4T1-A細(xì)胞

Abcam HEK293T GHITM KO 2 Cells(提供STR鑒定圖譜)

AG10312 Cells(提供STR鑒定圖譜)

BayGenomics ES cell line PST027 Cells(提供STR鑒定圖譜)

BayGenomics ES cell line XC739 Cells(提供STR鑒定圖譜)

BTF Cells(提供STR鑒定圖譜)

CPE/LULS50 Cells(提供STR鑒定圖譜)

DA04117 Cells(提供STR鑒定圖譜)

DA06042 Cells(提供STR鑒定圖譜)

GM00492 Cells(提供STR鑒定圖譜)

HEK 293 c18 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：４-１：１０傳代；每周２次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮細(xì)胞樣;相關(guān)產(chǎn)品有：HBEpiC細(xì)胞、OVCAR 420細(xì)胞、Ontario Cancer Institute-Acute Myeloid Leukemia-2細(xì)胞

FLS Cells;背景說(shuō)明：滑膜;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Hs68細(xì)胞、PC10細(xì)胞、SNU484細(xì)胞

Z138 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：５-１：１５傳代；每周２-３次。;生長(zhǎng)特性：懸浮生長(zhǎng);形態(tài)特性：淋巴母細(xì)胞;相關(guān)產(chǎn)品有：NCI-H520細(xì)胞、HeLa 229細(xì)胞、KATOIII細(xì)胞

Mo 59J Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：６-１：８?jìng)鞔?；每周換液２-３次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：成纖維細(xì)胞;相關(guān)產(chǎn)品有：GA-10 clone 4細(xì)胞、HuTu 80細(xì)胞、Ca759細(xì)胞

MKN-28 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：H820細(xì)胞、Japanese Tissue Culture-39細(xì)胞、HTh 74細(xì)胞

130-T Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：４傳代，３-４天換液１次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：梭型和大的多核細(xì)胞;相關(guān)產(chǎn)品有：G361-mel細(xì)胞、Pt-K2細(xì)胞、SUM 159PT細(xì)胞

TE15 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：N-Tera-2細(xì)胞、PAEC細(xì)胞、4T1-LUC細(xì)胞

H 9 Cells;背景說(shuō)明：H９細(xì)胞是HUT７８（ATCCTIB１６１）的克隆系（Callo，RC，etal）。細(xì)胞表面帶有CD３、CD４標(biāo)記。研究表明，該細(xì)胞系對(duì)人體免疫缺陷病毒（HIV-１）敏感，可用于檢測(cè)、分離和增殖HIV-１，也可用于其它人類Tcell病毒的研究。;傳代方法：１：３傳代,２-３天傳一代;生長(zhǎng)特性：懸浮生長(zhǎng);形態(tài)特性：淋巴母細(xì)胞樣;相關(guān)產(chǎn)品有：Tadarida brasiliensis 1 lung細(xì)胞、BE(2)C細(xì)胞、P3/NS1/1-Ag4.1細(xì)胞

SV-HUC-1人輸尿管上皮永生化細(xì)胞全年復(fù)蘇|已有STR圖譜

THEECs Cells;背景說(shuō)明：食管；上皮細(xì)胞；女性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：SK-N-BE2細(xì)胞、NTC200細(xì)胞、L-5178-Y-R細(xì)胞

ACC-2 Cells;背景說(shuō)明：涎腺腺樣囊性癌；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：NCIH226細(xì)胞、U373 MG細(xì)胞、Pt K1 (NBL-3)細(xì)胞

IPEC-J2 Cells;背景說(shuō)明：小腸；上皮細(xì)胞；自發(fā)永生;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：NT2細(xì)胞、Det. 562細(xì)胞、ACC-M細(xì)胞

L cell Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：C38細(xì)胞、CHO-K1細(xì)胞、Hep-G2細(xì)胞

OS-732 Cells;背景說(shuō)明：骨肉瘤;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：6T-CEM細(xì)胞、H-EMC-SS細(xì)胞、M-1細(xì)胞

OS-732 Cells;背景說(shuō)明：骨肉瘤;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：6T-CEM細(xì)胞、H-EMC-SS細(xì)胞、M-1細(xì)胞

Walker-256-TC Cells;背景說(shuō)明：乳腺癌；雌性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：CWR22R細(xì)胞、EFM192細(xì)胞、MV(4;11)細(xì)胞

HAP1 ATF3 (-) 1 Cells(提供STR鑒定圖譜)

HAP1 SLC44A3 (-) 1 Cells(提供STR鑒定圖譜)

BE2-C Cells;背景說(shuō)明：神經(jīng)母細(xì)胞瘤；骨髓轉(zhuǎn)移；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HCT/FU細(xì)胞、U-2-OS細(xì)胞、NCI-841細(xì)胞

alphaTC clone 6 Cells;背景說(shuō)明：胰島素瘤；a細(xì)胞；C５７BL/６xDBA/２;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：L細(xì)胞、PK(15)細(xì)胞、Hs 683.T細(xì)胞

CHG5 Cells;背景說(shuō)明：少突神經(jīng)膠質(zhì)瘤；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：BE2-M17細(xì)胞、OCI-Ly1細(xì)胞、UCLA-SO-M20細(xì)胞

TE8 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：消化３-５分鐘。１：２。３天內(nèi)可長(zhǎng)滿。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮樣;相關(guān)產(chǎn)品有：RASMC細(xì)胞、NKM-1細(xì)胞、PLA-801D細(xì)胞

H2228 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代，每周２-３次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Ocular Choroidal Melanoma-1細(xì)胞、N87細(xì)胞、210RCY3-Ag1.2.3細(xì)胞

87 MG Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Hs888 Lu細(xì)胞、KU.812細(xì)胞、HSC-T6細(xì)胞

CORL105 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HT-29細(xì)胞、Ontario Cancer Institute-Acute Myeloid Leukemia-3細(xì)胞、MDA-MB 361細(xì)胞

OCI-Ly3 Cells;背景說(shuō)明：彌漫大B淋巴瘤；男性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：C8166細(xì)胞、WERI-Rb-1細(xì)胞、PLA801D細(xì)胞

iBMK Atg5-/- 7.1B5 Cells(提供STR鑒定圖譜)

Lis08_AIS2 Cells(提供STR鑒定圖譜)

NCC-UPS3-C1 Cells(提供STR鑒定圖譜)

PathHunter CHO-K1 CXCR7 beta-arrestin Cells(提供STR鑒定圖譜)

S1123-03 iPS #1 Cells(提供STR鑒定圖譜)

TR-BE Cells(提供STR鑒定圖譜)

UiPSC-044 Cells(提供STR鑒定圖譜)

HEK-SC-293T Cells(提供STR鑒定圖譜)

WEHI 164 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HFLS-OA細(xì)胞、H-250細(xì)胞、Neuro-2a細(xì)胞

GM16136 Cells;背景說(shuō)明：肺；自發(fā)永生；雄性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：RGM1細(xì)胞、MUS-M1細(xì)胞、C3H10T1-2細(xì)胞

KS-1 [Human glioblastoma] Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：成纖維細(xì)胞;相關(guān)產(chǎn)品有：BEL 7405細(xì)胞、BC-021細(xì)胞、TE-7細(xì)胞

GES-1 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HCET細(xì)胞、PC-14細(xì)胞、GI-1細(xì)胞

3T3-442A Cells;背景說(shuō)明：脂肪前體細(xì)胞；雄性；Swiss albino;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：SK-MEL-MeWo細(xì)胞、PANC 327細(xì)胞、RKO-AS45-1細(xì)胞

3T3-442A Cells;背景說(shuō)明：脂肪前體細(xì)胞；雄性；Swiss albino;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：SK-MEL-MeWo細(xì)胞、PANC 327細(xì)胞、RKO-AS45-1細(xì)胞

GH3 Cells;背景說(shuō)明：GH３細(xì)胞系是由TashjianAH等在１９６５年７月從一只７月齡的雌性Wistar-Furth大鼠的垂體腫瘤中分離建立的。GH３細(xì)胞系不是直接來(lái)源于GH１細(xì)胞系的克隆，而是從原代培養(yǎng)的GH１細(xì)胞在大鼠身上傳代兩次形成的腫瘤中建立的。上皮樣的GH３細(xì)胞比GH１分泌更高水平的生長(zhǎng)激素，也可產(chǎn)生催乳素。對(duì)調(diào)控GH３細(xì)胞分泌蛋白類激素的研究表明，化可的松可以刺激生長(zhǎng)激素的分泌、抑制催乳素的產(chǎn)生。;傳代方法：１：２傳代;生長(zhǎng)特性：疏松貼壁，有漂浮的細(xì)胞簇;形態(tài)特性：上皮樣;相關(guān)產(chǎn)品有：UPCI-SCC090細(xì)胞、HCT15細(xì)胞、293T細(xì)胞

BALL1 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：懸浮生長(zhǎng);形態(tài)特性：淋巴母細(xì)胞;相關(guān)產(chǎn)品有：Wien 133細(xì)胞、HEH2細(xì)胞、UCLA-SO-M21細(xì)胞

A2780-CP Cells;背景說(shuō)明：卵巢癌；女性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Hs 578.T細(xì)胞、NG10815細(xì)胞、KM-H2細(xì)胞

OACP4 C Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：H1581細(xì)胞、LLCPK1細(xì)胞、MOLT4細(xì)胞

3D4/21 Cells;背景說(shuō)明：肺泡巨噬細(xì)胞；SV４０轉(zhuǎn)化；Landrace;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：32D CL3細(xì)胞、MNNG/HOS Cl #5細(xì)胞、TFH細(xì)胞

38C13 Cells;背景說(shuō)明：B淋巴瘤；C３H/eB;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：半貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：YH細(xì)胞、P31-FUJ細(xì)胞、Tn5 B1-4細(xì)胞

H929 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：保持細(xì)胞密度在５×１０５—１×１０６ cells/ml之間，每周換液２—３次;生長(zhǎng)特性：懸浮生長(zhǎng) ;形態(tài)特性：淋巴母細(xì)胞樣;相關(guān)產(chǎn)品有：639 V細(xì)胞、VK-2/E6E7細(xì)胞、NOK細(xì)胞

ECC 10 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：LC1-Sq細(xì)胞、HCC-2218細(xì)胞、HEEpiC細(xì)胞

MN 60 Cells;背景說(shuō)明：B細(xì)胞白血?。荒行?傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：懸浮;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：NCI-H719細(xì)胞、639-V細(xì)胞、MZCRC1細(xì)胞

TK-1 [Human astrocytoma] Cells(提供STR鑒定圖譜)

BTT739 Cells;背景說(shuō)明：膀胱移行細(xì)胞癌 Cells;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：U-937細(xì)胞、H1869細(xì)胞、My-La 2059細(xì)胞

EC9706 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮細(xì)胞樣;相關(guān)產(chǎn)品有：EA hy 926細(xì)胞、COR-L 105細(xì)胞、McA-RH 8994細(xì)胞

Ramos 1 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HBE 135-E6/E7細(xì)胞、SK-N-BE-2c細(xì)胞、Sc-1細(xì)胞

Kit 225 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：NCC-IT細(xì)胞、MC3T3-L1細(xì)胞、NFHIOSE-29細(xì)胞

GM05887A Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２—１：５傳代；每周換液２-３次;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：混合型;相關(guān)產(chǎn)品有：MDCK Type II細(xì)胞、H2196細(xì)胞、CORL51細(xì)胞

HEMCSS Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：４-１：８?jìng)鞔?；每周換液３次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：STTG1細(xì)胞、SKCO 1細(xì)胞、RL95細(xì)胞

Hs 675.T Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代，每周２-３次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：成纖維細(xì)胞;相關(guān)產(chǎn)品有：PanC1細(xì)胞、KYSE-270細(xì)胞、NHEK細(xì)胞

H810 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：６傳代,每周２-３次。;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮樣;相關(guān)產(chǎn)品有：C-6細(xì)胞、L-929細(xì)胞、SW 756細(xì)胞

SV-HUC-1人輸尿管上皮永生化細(xì)胞全年復(fù)蘇|已有STR圖譜

AG 9 Cells;背景說(shuō)明：皮下結(jié)締組織；自發(fā)永生；雄性；C３H/An;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Ramos-RA1細(xì)胞、IAR20細(xì)胞、NCIH345細(xì)胞

S3 HeLa Cells;背景說(shuō)明：該細(xì)胞是１９５５年由PuckTT,MarcusPI和CieciuraSJ建系的，含HPV-１８序列；角蛋白陽(yáng)性；可用于與染色體突變、細(xì)胞營(yíng)養(yǎng)、集落形成相關(guān)的哺乳動(dòng)物細(xì)胞的克隆分析。;傳代方法：１：２傳代;生長(zhǎng)特性：貼壁生長(zhǎng);形態(tài)特性：上皮樣;相關(guān)產(chǎn)品有：MDA-MB 231細(xì)胞、EL-4細(xì)胞、FLS細(xì)胞

L cell line Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：IBMF-7細(xì)胞、H-1563細(xì)胞、MCF 10A細(xì)胞

HEK-293 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：Ramos 2G6.4C10細(xì)胞、MDA.MB.435細(xì)胞、H1341細(xì)胞

OVCA420 Cells;背景說(shuō)明：卵巢癌；女性;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：OCI AML3細(xì)胞、NCIH524細(xì)胞、UMR106細(xì)胞

GalK1 Cells;背景說(shuō)明：詳見(jiàn)相關(guān)文獻(xiàn)介紹;傳代方法：１：２-１：３傳代；每周換液２-３次。;生長(zhǎng)特性：貼壁或懸浮，詳見(jiàn)產(chǎn)品說(shuō)明書部分;形態(tài)特性：詳見(jiàn)產(chǎn)品說(shuō)明書;相關(guān)產(chǎn)品有：HFF1細(xì)胞、Co320細(xì)胞、Statens Seruminstitut Rabbit Cornea細(xì)胞

BayGenomics ES cell line CSH580 Cells(提供STR鑒定圖譜)

BayGenomics ES cell line RRZ229 Cells(提供STR鑒定圖譜)

BNL CL.2 High Passage Cells(提供STR鑒定圖譜)

KU-Lu-5 Cells(提供STR鑒定圖譜)

PGF3-11 Cells(提供STR鑒定圖譜)

Per305 Cells(提供STR鑒定圖譜)

" "Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix

Lingjuan Cui, Xiaoyan Jiang, Chengjun Zhang, Danxia Li, Shengqiang Yu, Fengchun Wan, Yue Ma, Wei Guo, Zhengfei Shan

Biosci Rep. 2019 Oct 30; 39(10): BSR20190595. Published online 2019 Oct 18. doi: 10.1042/BSR20190595

PMCID: PMC6811748

Hypoxia impairs urothelial barrier function by inhibiting the expression of tight junction proteins in SV‐HUC‐1 cells

Huijiu Luo, Hui Zhou, Yuzhu Chen, Xianwu Sun, Yihuan Li, Guangjie Li, Shouyi Long, Shiyu Wang, Guobiao Liang, Shulian Chen

J Cell Mol Med. 2024 Jul; 28(14): e18545. Published online 2024 Jul 19. doi: 10.1111/jcmm.18545

PMCID: PMC11258885

Matrine Suppresses Arsenic-Induced Malignant Transformation of SV-HUC-1 Cells via NOX2

Lanfei Wang, Nianfeng Qiu, Suyuan Tong, Yan Yu, Shuhua Xi, Fei Wang

Int J Mol Sci. 2024 Aug; 25(16): 8878. Published online 2024 Aug 15. doi: 10.3390/ijms25168878

PMCID: PMC11354282

Platelet Lysate Therapy Attenuates Hypoxia Induced Apoptosis in Human Uroepithelial SV-HUC-1 Cells through Regulating the Oxidative Stress and Mitochondrial-Mediated Intrinsic Apoptotic Pathway

Zong-Sheng Wu, Hou-Lun Luo, Yao-Chi Chuang, Wei-Chia Lee, Hung-Jen Wang, Michael B. Chancellor

Biomedicines. 2023 Mar; 11(3): 935. Published online 2023 Mar 17. doi: 10.3390/biomedicines11030935

PMCID: PMC10045666

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures

Tomasz Kloskowski, Zuzanna Fekner, Kamil Szeliski, Michelle Paradowska, Daria Balcerczyk, Marta Rasmus, Pawe? D?browski, ?ukasz Ka?mierski, Tomasz Drewa, Marta Pokrywczyńska

Front Oncol. 2023; 13: 1222411. Published online 2023 Jul 18. doi: 10.3389/fonc.2023.1222411

PMCID: PMC10390741

Mycoplasma genitalium Protein of Adhesion Promotes the Early Proliferation of Human Urothelial Cells by Interacting with RPL35

Pei Dai, Xiangying Deng, Peng Liu, Lingling Li, Dan Luo, Yating Liao, Yanhua Zeng

Pathogens. 2021 Nov; 10(11): 1449. Published online 2021 Nov 8. doi: 10.3390/pathogens10111449

PMCID: PMC8621731

An experimental model of the epithelial to mesenchymal transition and pro-fibrogenesis in urothelial cells related to bladder pain syndrome/interstitial cystitis

Xing-Wei Jin, Qi-Zhang Wang, Yang Zhao, Bo-Ke Liu, Xiang Zhang, Xian-Jin Wang, Guo-Liang Lu, Jun-Wei Pan, Yuan Shao

Transl Androl Urol. 2021 Nov; 10(11): 4120–4131. doi: 10.21037/tau-21-392

PMCID: PMC8661263

Mycoplasma genitalium Protein of Adhesion Induces Inflammatory Cytokines via Cyclophilin A-CD147 Activating the ERK-NF-κB Pathway in Human Urothelial Cells

Lingling Li, Dan Luo, Yating Liao, Kailan Peng, Yanhua Zeng

Front Immunol. 2020; 11: 2052. Published online 2020 Sep 9. doi: 10.3389/fimmu.2020.02052

PMCID: PMC7509115

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

Sayani Bhattacharjee, Matthew J. Sullivan, Rebecca R. Wynn, Alex Demagall, Andrew S. Hendrix, Puneet Sindhwani, Firas G. Petros, Nagalakshmi Nadiminty

BMC Cancer. 2022; 22: 312. Published online 2022 Mar 23. doi: 10.1186/s12885-022-09376-9

PMCID: PMC8944004

ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors’ secretion in arsenite-treated human uroepithelial cells

Shengnan Liu, Fei Wang, Jieyu Liu, Peiyu Jin, Xiaoyan Wang, Li Yang, Shuhua Xi

Toxicol Res (Camb) 2017 Jul 1; 6(4): 468–476. Published online 2017 Mar 29. doi: 10.1039/c6tx00407e

PMCID: PMC6062379

The PI3K-AKT-mTOR signaling pathway mediates the cytoskeletal remodeling and epithelial-mesenchymal transition in bladder outlet obstruction

Zhaoxia Zhang, Chenghao Zhanghuang, Tao Mi, Liming Jin, Jiayan Liu, Maoxian Li, Xin Wu, Jinkui Wang, Mujie Li, Zhang Wang, Peng Guo, Dawei He

Heliyon. 2023 Nov; 9(11): e21281. Published online 2023 Nov 2. doi: 10.1016/j.heliyon.2023.e21281

PMCID: PMC10663759

Curcumin reversed chronic tobacco smoke exposure induced urocystic EMT and acquisition of cancer stem cells properties via Wnt/β-catenin

Zhaofeng Liang, Ling Lu, Jiahui Mao, Xia Li, Hui Qian, Wenrong Xu

Cell Death Dis. 2017 Oct; 8(10): e3066. Published online 2017 Oct 5. doi: 10.1038/cddis.2017.452

PMCID: PMC5680574

Insulin Downregulated the Infection of Uropathogenic Escherichia coli (UPEC) in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway

Chen-Hsun Ho, Shih-Ping Liu, Chia-Kwung Fan, Kai-Yi Tzou, Chia-Chang Wu, Po-Ching Cheng

Microorganisms. 2021 Dec; 9(12): 2421. Published online 2021 Nov 24. doi: 10.3390/microorganisms9122421

PMCID: PMC8704104

Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models

?ukasz Nowak, Wojciech Krajewski, Ewa Dejnaka, Bartosz Ma?kiewicz, Tomasz Szyde?ko, Aleksandra Pawlak

Biomedicines. 2023 Mar; 11(3): 759. Published online 2023 Mar 2. doi: 10.3390/biomedicines11030759

PMCID: PMC10045593

Biomimetic Human Tissue Model for Long-Term Study of Neisseria gonorrhoeae Infection

Motaharehsadat Heydarian, Tao Yang, Matthias Schweinlin, Maria Steinke, Heike Walles, Thomas Rudel, Vera Kozjak-Pavlovic

Front Microbiol. 2019; 10: 1740. Published online 2019 Jul 31. doi: 10.3389/fmicb.2019.01740

PMCID: PMC6685398

Antimicrobial Peptide LCN2 Inhibited Uropathogenic Escherichia coli Infection in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway

Pei-Chi Chen, Chen-Hsun Ho, Chia-Kwung Fan, Shih-Ping Liu, Po-Ching Cheng

Int J Mol Sci. 2022 Dec; 23(24): 15763. Published online 2022 Dec 12. doi: 10.3390/ijms232415763

PMCID: PMC9779052

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate

Wei Xiang, Yongbo Peng, Hongliang Zeng, Chunping Yu, Qun Zhang, Biao Liu, Jiahao Liu, Xing Hu, Wensu Wei, Minhua Deng, Ning Wang, Xuewen Liu, Jianfei Xie, Weibin Hou, Jin Tang, Zhi Long, Long Wang, Jianye Liu

Biomater Res. 2022; 26: 74. Published online 2022 Dec 5. doi: 10.1186/s40824-022-00328-9

PMCID: PMC9721011

Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation

Dayin Chen, Tingyu Chen, Yingxue Guo, Chennan Wang, Longxin Dong, Chunfeng Lu

Braz J Med Biol Res. 2021; 54(3): e10222. Published online 2021 Jan 15. doi: 10.1590/1414-431X202010222

Correction in: Braz J Med Biol Res. 2022; 55: e10222erratum.

Retraction in: Braz J Med Biol Res. 2022; 55: e10222retraction.

PMCID: PMC7814303

Article

Ketamine enhances autophagy and endoplasmic reticulum stress in rats and SV-HUC-1 cells via activating IRE1-TRAF2-ASK1-JNK pathway

Yanming Yu, Daoxu Wu, Yongwei Li, Hui Qiao, Zhengfei Shan

Cell Cycle. 2021; 20(18): 1907–1922. Published online 2021 Aug 24. doi: 10.1080/15384101.2021.1966199

PMCID: PMC8525958

ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-?B/CD44 pathway in urinary bladder carcinoma

Mengzhao Zhang, Lu Wang, Yangyang Yue, Lu Zhang, Tianjie Liu, Minxuan Jing, Xiao Liang, Minghai Ma, Shan Xu, Ke Wang, Xinyang Wang, Jinhai Fan

J Exp Clin Cancer Res. 2021; 40: 65. Published online 2021 Feb 11. doi: 10.1186/s13046-021-01866-1

PMCID: PMC7877014"